IBDEI0SM ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14130,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14130,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,14130,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,14130,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,14131,0)
 ;;=131.02^^90^856^57
 ;;^UTILITY(U,$J,358.3,14131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14131,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,14131,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,14131,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,14132,0)
 ;;=597.80^^90^856^55
 ;;^UTILITY(U,$J,358.3,14132,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14132,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,14132,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,14132,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,14133,0)
 ;;=788.41^^90^856^58
 ;;^UTILITY(U,$J,358.3,14133,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14133,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,14133,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,14133,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,14134,0)
 ;;=788.31^^90^856^62
 ;;^UTILITY(U,$J,358.3,14134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14134,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,14134,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,14134,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,14135,0)
 ;;=788.20^^90^856^63
 ;;^UTILITY(U,$J,358.3,14135,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14135,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,14135,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,14135,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,14136,0)
 ;;=112.2^^90^856^66
 ;;^UTILITY(U,$J,358.3,14136,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14136,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,14136,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,14136,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,14137,0)
 ;;=600.01^^90^856^5
 ;;^UTILITY(U,$J,358.3,14137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14137,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,14137,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,14137,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,14138,0)
 ;;=600.10^^90^856^40
 ;;^UTILITY(U,$J,358.3,14138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14138,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,14138,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,14138,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,14139,0)
 ;;=585.9^^90^856^8
 ;;^UTILITY(U,$J,358.3,14139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14139,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,14139,1,5,0)
 ;;=5^Chronic Renal Failure
 ;;^UTILITY(U,$J,358.3,14139,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,14140,0)
 ;;=788.64^^90^856^59
 ;;^UTILITY(U,$J,358.3,14140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14140,1,4,0)
 ;;=4^788.64
 ;;^UTILITY(U,$J,358.3,14140,1,5,0)
 ;;=5^Urinary Hesitancy
 ;;^UTILITY(U,$J,358.3,14140,2)
 ;;=^334165
 ;;^UTILITY(U,$J,358.3,14141,0)
 ;;=788.65^^90^856^52
 ;;^UTILITY(U,$J,358.3,14141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14141,1,4,0)
 ;;=4^788.65
 ;;^UTILITY(U,$J,358.3,14141,1,5,0)
 ;;=5^Straining of Urination
 ;;^UTILITY(U,$J,358.3,14141,2)
 ;;=^334166
 ;;^UTILITY(U,$J,358.3,14142,0)
 ;;=600.00^^90^856^4
 ;;^UTILITY(U,$J,358.3,14142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14142,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,14142,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,14142,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,14143,0)
 ;;=599.70^^90^856^20
 ;;^UTILITY(U,$J,358.3,14143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14143,1,4,0)
 ;;=4^599.70
 ;;^UTILITY(U,$J,358.3,14143,1,5,0)
 ;;=5^Hematuria
 ;;^UTILITY(U,$J,358.3,14143,2)
 ;;=^336751
